Pulmonary Disease, Chronic Obstructive  >>  budesonide/formoterol  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
budesonide/formoterol / Generic mfg.
NCT00239278: Budesonide / Formoterol in Treatment of Exacerbations of COPD

Completed
2
120
Europe
budesonide/formoterol, 2x 200/6 microgram. 4 times daily, Symbicort, prednisolone, 30 mg once daily and placebo
AstraZeneca
Chronic Obstructive Pulmonary Disease
 
01/05

Download Options